Table 3 Adopters per drug and specialty and time of adoption
From: Adoption of new drugs by physicians: a survival analysis
Time of adoption | ||||||
|---|---|---|---|---|---|---|
Drug | Specialty | Number of prescribers | Number of adopters (%) | Median in months (intercuartile range) | Comparison with Family Physicians. Log-rank test | |
χ 2 | p-value | |||||
Cefditoren | Otolaryngology | 19 | 11 (58%) | 2 (2-5) | 6.76 | 0.01 |
Family physicians | 232 | 50 (22%) | 4 (3-7) | |||
Internal medicine | 22 | 4 (18%) | 5 (3-10) | 0.44 | NS | |
Emergencies | 65 | 7 (11%) | 9 (5-21) | 6.39 | 0.01 | |
Pneumology | 15 | 7 (47%) | 9 (8-12) | 1.14 | NS | |
Duloxetine | Psychiatry | 36 | 22 (61%) | 2 (2-3) | 29.55 | < 0.01 |
Family physicians | 252 | 160 (63%) | 4 (3-6) | |||
Etoricoxib | Rheumatology | 6 | 3 (50%) | 2 (1-8) | 8.08 | < 0.01 |
Traumatology | 55 | 21 (38%) | 3 (2-15) | 1.97 | NS | |
Family physicians | 230 | 105 (46%) | 10 (3-20) | |||
Rehabilitation | 14 | 2 (14%) | 11 (11-26) | 0.51 | NS | |
Ezetimibe | Cardiology | 16 | 6 (38%) | 2 (1-3) | 8.13 | < 0.01 |
Endocrinology | 11 | 8 (73%) | 3 (2-3) | 10.95 | < 0.01 | |
Family physicians | 258 | 168 (65%) | 5 (3-8) | |||
Levocetirizine | Otolaryngology | 19 | 8 (42%) | 1 (1-4) | 24.14 | < 0.01 |
Allergology | 10 | 10 (100%) | 4 (2-7) | 4.96 | 0.03 | |
Emergencies | 44 | 4 (9%) | 4 (4-12) | 0.73 | NS | |
Dermatology | 15 | 12 (80%) | 9 (2-12) | 1.54 | NS | |
Family physicians | 264 | 141 (53%) | 10 (7-13) | |||
Olmesartan | Cardiology | 15 | 3 (20%) | 1 (1-2) | 17.23 | < 0.01 |
Internal medicine | 21 | 3 (14%) | 2 (2-13) | 0.04 | NS | |
Family physicians | 256 | 154 (60%) | 6 (3-9) | |||
Pregabalin | Anesthesiology | 8 | 3 (38%) | 2 (2-5) | 8.45 | < 0.01 |
Neurology | 17 | 8 (47%) | 3 (2-4) | 12.1 | < 0.01 | |
Rheumatology | 6 | 6 (100%) | 3 (2-4) | 9.83 | < 0.01 | |
Rehabilitation | 23 | 17 (74%) | 5 (2-7) | 2.94 | NS | |
Family physicians | 275 | 180 (65%) | 6 (4-10) | |||
Traumatology | 56 | 17 (30%) | 6 (4-9) | 0.87 | NS | |
Tiotropium | Pneumology | 15 | 14 (93%) | 1 (1-2) | 49.18 | < 0.01 |
Internal medicine | 30 | 14 (47%) | 2 (2-5) | 0.13 | NS | |
Family physicians | 297 | 207 (70%) | 3 (2-4) | |||